Global Electroceuticals / Bioelectric Medicine Market Size, Share & Trends Analysis Report, By Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Other), By Type (Implantable Electroceutical Devices, Non-invasive Electroceutical Devices.) By Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson?s Disease, Tremor, Depression, Treatment-resistant Depression, Epilepsy, Urinary and Fecal Incontinence, Others), By End Use, and By Region, And Segment Forecasts, Till 2030.

Report ID : AMR1005005 | Industries : Healthcare | Published On :January 2024 | Page Count : 222

Global Electroceuticals / Bioelectric Medicine Market Size, Share & Trends Analysis Report, By Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Other), By Type (Implantable Electroceutical Devices, Non-invasive Electroceutical Devices.) By Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson’s Disease, Tremor, Depression, Treatment-resistant Depression, Epilepsy, Urinary and Fecal Incontinence, Others), By End Use, and By Region, And Segment Forecasts, Till – 2030.

Market Overview

According to Analytical Market Research, the global Electroceuticals / Bioelectric Medicine market estimated at USD 25.12 billion in 2022 and will expand at a compound annual growth rate (CAGR) of 6.81% from 2023 to 2030.

Molecular medicine, neurology, as well as bioengineering included in electroceuticals/bioelectric medicine, which develops nerve stimulation technologies for biological parameters during treatment. By using electrical impulses, it alters how the body functions.

Electroceuticals / Bioelectric Medicine Market Dynamics: Key Drivers & Restraints

Rising Prevalence of Chronic Diseases Growing prevalence of chronic diseases like cardiac and neurological disorders is expected to be a major factor driving the market. For instance, as per the information provided by the Centers for Disease Control and Prevention, cardiovascular diseases are responsible for the majority of deaths among women, men, and most racial and ethnic groups in the U.S. In the year 2021, approximately 695,000 individuals in the United States died from heart diseases, accounting for one in every five deaths.
Furthermore, rising investments in research & development by manufacturers and the growth rate of regulatory approvals for new electroceuticals/bioelectric medicines are major factors contributing to the growth of the market.
Moreover, the presence of well-established market players supporting the market growth in the region. Besides, favourable government support as well as regional product approvals also drive market growth.
Stringent government rules will restraint the market growth
Stringent government rules regarding the development & manufacturing of medical devices, including implantable cardioverter defibrillators, cardiac pacemakers, and neuromodulation devices could hamper the growth of the market. These devices undergo rigorous clinical trials before a premarket approval (PMA), which causes a significant increase in the costs incurred by manufacturers. In addition, product recalls are a major challenging factor that could adversely affect the market growth.

How are Segments Performing in the Global Electroceuticals / Bioelectric Medicine Market?

Electroceuticals / Bioelectric Medicine Product Segment Breakdown
According to Analytical Market Research, the Electroceuticals / Bioelectric Medicine market by product is segmented into Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Other
Electroceuticals / Bioelectric Medicine Type Segment Breakdown
According to Analytical Market Research, based on platform, the market is bifurcated into Implantable Electroceutical Devices, Non-invasive Electroceutical Devices.
Electroceuticals / Bioelectric Medicine Application Segment Breakdown
According to Analytical Market Research, based on application, the market is bifurcated into Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson’s Disease, Tremor, Depression, Treatment-resistant Depression, Epilepsy, Urinary and Fecal Incontinence, Others.
Electroceuticals / Bioelectric Medicine End Use Segment Breakdown
According to Analytical Market Research, based on End Use, the market is bifurcated into Hospitals, Clinics, and others.
Electroceuticals / Bioelectric Medicine Geographic Exploration
According to Analytical Market Research, the North America region is predicted to dominate the market, owing to the strong presence of medical device manufacturers. Moreover, the highly developed healthcare system as well as the availability of advanced products have fueled the growth of the regional market. North America was followed by Europe, due to the increasing demand for innovative medical devices for treatment procedures. Other regions competing in the market are North America, Europe, Middle East and Africa and Latin America respectively.

COMPETITIVE LANDSCAPE & RECENT DEVELOPMENT: Electroceuticals / Bioelectric Medicine

The competitive landscape of the market is fragmented and competitive. The significant players rapidly evolve with new strategies to attain a competitive edge & capture significant market share.

• For Instance, in July 2023, Boston Scientific Corporation received FDA approval for its Vercise Neural Navigator 5 software. This is designed to be used alongside the Vercise Genus deep brain stimulation (DBS) systems, providing clinicians with straightforward & practical data for the treatment of individuals with Parkinson's disease/essential tremor. Clinicians can efficiently program the DBS system & deliver optimal treatment to patients with this software.
• For Instance, in February 2023, LivaNova introduced a new device called SenTiva DUO, an implantable pulse generator which aims to treat epilepsy in patients resistant to drug therapy. The device is specifically intended to deliver Vagus Nerve Stimulation therapy & it has a dual-pin header. The latest technology treats & provide benefits to patients who have been embedded with a dual-pin lead and IPG.

Noticeable Players Functioning in The Global Electroceuticals / Bioelectric Medicine Market Include:

• Stimwave LLC
• Nevro Corp.
• Sonova
• electroCore, Inc.
• Biotronik SE & Co. KG
• LivaNova PLC
• Cochlear Ltd.
• Boston Scientific Corporation
• Abbott
• Medtronic

KEY BREAKDOWN: Electroceuticals / Bioelectric Medicine Market

By Product:
• Implantable Cardioverter Defibrillators
• Cardiac Pacemakers
• Cochlear Implants
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Transcutaneous Electrical Nerve Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Other
By Type
• Implantable Electroceutical Devices
• Non-invasive Electroceutical Devices
By Application
• Arrhythmia
• Pain Management
• Sensorineural Hearing Loss
• Parkinson’s Disease
• Tremor
• Depression
• Treatment-resistant Depression
• Epilepsy
• Urinary and Fecal Incontinence
• Others
By End Use
• Hospitals
• Clinics
• Others
Geographical Exploration:
• North America
o The USA
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Southeast Asia
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of Latin America
• Middle East and Africa
o GCC Countries
o South Africa
o Rest of MEA

1. Research Methodology
1.1. Global Electroceuticals / Bioelectric Medicine Market Snapshot, 2023 and 2030
1.2. Data Mining
1.3. Validation
1.4. Primary Interviews
1.5. List of Data Sources
1.6. Future Market Projections
1.7. Industry Developments and Key Market Events
2. Executive Summary
3. Market Overview
3.1. Market Scope and Definition
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunity
3.2.4. Challenges
3.2.5. Cumulative Impact due to Recent Energy Crisis
3.2.6. Cumulative Impact due to Nearing Economic Downturn
3.2.7. Post Covid-19 World Supply & Demand Conditions
3.2.8. Cumulative Impact of Russia-Ukraine Conflict
3.2.9. Key Trends
3.3. Electroceuticals / Bioelectric Medicine Market: Value Chain
3.3.1. List of Raw Material Supplier
3.3.2. List of Manufacturers
3.3.3. List of Applications
3.4. Porter Five Force’s Analysis
3.5. Regulatory and Technology Landscape
4. Global Electroceuticals / Bioelectric Medicine Market Outlook: Forecast (2023 – 2030)
4.1. Key Highlights
4.1.1. Market Size and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Current Market Size Forecast, 2023–2030
4.3. Global Electroceuticals / Bioelectric Medicine Market Outlook: Product
4.3.1. Introduction / Key Findings
4.3.2. Market Size (US$ Mn) and Forecast Product, 2023 – 2030
4.3.2.1. Implantable Cardioverter Defibrillators
4.3.2.2. Cardiac Pacemakers
4.3.2.3. Cochlear Implants
4.3.2.4. Spinal Cord Stimulators
4.3.2.5. Deep Brain Stimulators
4.3.2.6. Transcutaneous Electrical Nerve Stimulators
4.3.2.7. Sacral Nerve Stimulators
4.3.2.8. Vagus Nerve Stimulators
4.3.2.9. Other
4.4. Global Electroceuticals / Bioelectric Medicine Market Outlook: Type
4.4.1. Introduction / Key Findings
4.4.2. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
4.4.2.1. Implantable Electroceutical Devices
4.4.2.2. Non-invasive Electroceutical Devices
4.5. Global Electroceuticals / Bioelectric Medicine Market Outlook: Application
4.5.1. Introduction / Key Findings
4.5.2. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
4.5.2.1. Arrhythmia
4.5.2.2. Pain Management
4.5.2.3. Sensorineural Hearing Loss
4.5.2.4. Parkinson’s Disease
4.5.2.5. Tremor
4.5.2.6. Depression
4.5.2.7. Treatment-resistant Depression
4.5.2.8. Epilepsy
4.5.2.9. Urinary and Fecal Incontinence
4.5.2.10. Others
4.6. Global Electroceuticals / Bioelectric Medicine Market Outlook: End Use
4.6.1. Introduction / Key Findings
4.6.2. Market Size (US$ Mn) and Forecast By End Use, 2023 – 2030
4.6.2.1. Hospitals
4.6.2.2. Clinics
4.6.2.3. Others
5. Global Electroceuticals / Bioelectric Medicine Market Outlook: Region
5.1. Key Highlights
5.2. Market Size (US$ Mn) and Forecast By Region, 2023 – 2030
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Latin America
5.2.5. Middle East & Africa (MEA)
6. North America Electroceuticals / Bioelectric Medicine Market Outlook: Forecast (2023 – 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2022
6.3.1. By Country
6.3.2. By Product
6.3.3. By Technology
6.3.4. By Application
6.3.5. By End Use
6.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
6.4.1. U.S.
6.4.2. Canada
6.4.3. Mexico
6.5. Market Size (US$ Mn) and Forecast By Product, 2023 – 2030
6.5.1. Implantable Cardioverter Defibrillators
6.5.2. Cardiac Pacemakers
6.5.3. Cochlear Implants
6.5.4. Spinal Cord Stimulators
6.5.5. Deep Brain Stimulators
6.5.6. Transcutaneous Electrical Nerve Stimulators
6.5.7. Sacral Nerve Stimulators
6.5.8. Vagus Nerve Stimulators
6.5.9. Other
6.6. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
6.6.1. Implantable Electroceutical Devices
6.6.2. Non-invasive Electroceutical Devices
6.7. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
6.7.1. Arrhythmia
6.7.2. Pain Management
6.7.3. Sensorineural Hearing Loss
6.7.4. Parkinson’s Disease
6.7.5. Tremor
6.7.6. Depression
6.7.7. Treatment-resistant Depression
6.7.8. Epilepsy
6.7.9. Urinary and Fecal Incontinence
6.7.10. Others
6.8. Market Size (US$ Mn) and Forecast By End Use, 2023 – 2030
6.8.1. Hospitals
6.8.2. Clinics
6.8.3. Others
7. Europe Electroceuticals / Bioelectric Medicine Market Outlook: Forecast (2023 – 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
7.3.1. By Country
7.3.2. By Product
7.3.3. By Type
7.3.4. By Application
7.3.5. By End Use
7.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
7.4.1. Germany
7.4.2. France
7.4.3. U.K.
7.4.4. Russia
7.4.5. Italy
7.4.6. Spain
7.4.7. Rest of Europe
7.5. Market Size (US$ Mn) and Forecast By Product, 2023 – 2030
7.5.1. Implantable Cardioverter Defibrillators
7.5.2. Cardiac Pacemakers
7.5.3. Cochlear Implants
7.5.4. Spinal Cord Stimulators
7.5.5. Deep Brain Stimulators
7.5.6. Transcutaneous Electrical Nerve Stimulators
7.5.7. Sacral Nerve Stimulators
7.5.8. Vagus Nerve Stimulators
7.5.9. Other
7.6. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
7.6.1. Implantable Electroceutical Devices
7.6.2. Non-invasive Electroceutical Devices
7.7. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
7.7.1. Arrhythmia
7.7.2. Pain Management
7.7.3. Sensorineural Hearing Loss
7.7.4. Parkinson’s Disease
7.7.5. Tremor
7.7.6. Depression
7.7.7. Treatment-resistant Depression
7.7.8. Epilepsy
7.7.9. Urinary and Fecal Incontinence
7.7.10. Others
7.8. Market Size (US$ Mn) and Forecast By End Use, 2023 – 2030
7.8.1. Hospitals
7.8.2. Clinics
7.8.3. Others
8. Asia Pacific Electroceuticals / Bioelectric Medicine Market Outlook: Forecast (2023 – 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
8.3.1. By Country
8.3.2. By Product
8.3.3. By Type
8.3.4. By Application
8.3.5. By End Use
8.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. New Zealand
8.4.7. Singapore
8.4.8. Malaysia
8.4.9. Rest of Asia
8.5. Market Size (US$ Mn) and Forecast By Product, 2023 – 2030
8.5.1. Implantable Cardioverter Defibrillators
8.5.2. Cardiac Pacemakers
8.5.3. Cochlear Implants
8.5.4. Spinal Cord Stimulators
8.5.5. Deep Brain Stimulators
8.5.6. Transcutaneous Electrical Nerve Stimulators
8.5.7. Sacral Nerve Stimulators
8.5.8. Vagus Nerve Stimulators
8.5.9. Other
8.6. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
8.6.1. Implantable Electroceutical Devices
8.6.2. Non-invasive Electroceutical Devices
8.7. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
8.7.1. Arrhythmia
8.7.2. Pain Management
8.7.3. Sensorineural Hearing Loss
8.7.4. Parkinson’s Disease
8.7.5. Tremor
8.7.6. Depression
8.7.7. Treatment-resistant Depression
8.7.8. Epilepsy
8.7.9. Urinary and Fecal Incontinence
8.7.10. Others
8.8. Market Size (US$ Mn) and Forecast By End Use, 2023 – 2030
8.8.1. Hospitals
8.8.2. Clinics
8.8.3. Others
9. Latin America Electroceuticals / Bioelectric Medicine Market Outlook: Forecast (2023 – 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
9.3.1. By Country
9.3.2. By Product
9.3.3. By Type
9.3.4. By Application
9.3.5. By End Use
9.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Colombia
9.4.4. Peru
9.4.5. Chile
9.4.6. Venezuela
9.4.7. Rest of Latin America
9.5. Market Size (US$ Mn) and Forecast By Product, 2023 – 2030
9.5.1. Implantable Cardioverter Defibrillators
9.5.2. Cardiac Pacemakers
9.5.3. Cochlear Implants
9.5.4. Spinal Cord Stimulators
9.5.5. Deep Brain Stimulators
9.5.6. Transcutaneous Electrical Nerve Stimulators
9.5.7. Sacral Nerve Stimulators
9.5.8. Vagus Nerve Stimulators
9.5.9. Others
9.6. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
9.6.1. Implantable Electroceutical Devices
9.6.2. Non-invasive Electroceutical Devices
9.7. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
9.7.1. Arrhythmia
9.7.2. Pain Management
9.7.3. Sensorineural Hearing Loss
9.7.4. Parkinson’s Disease
9.7.5. Tremor
9.7.6. Depression
9.7.7. Treatment-resistant Depression
9.7.8. Epilepsy
9.7.9. Urinary and Fecal Incontinence
9.7.10. Others
9.8. Market Size (US$ Mn) and Forecast By End Use, 2023 – 2030
9.8.1. Hospitals
9.8.2. Clinics
9.8.3. Others
10. Middle East & Africa Electroceuticals / Bioelectric Medicine Market Outlook: Forecast (2023 – 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2023 – 2030
10.3.1. By Country
10.3.2. By Product
10.3.3. By Type
10.3.4. By Application
10.3.5. By End Use
10.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
10.4.1. Saudi Arabia
10.4.2. UAE
10.4.3. Egypt
10.4.4. Kuwait
10.4.5. South Africa
10.4.6. Rest of Middle East & Africa
10.5. Market Size (US$ Mn) and Forecast By Product, 2023 – 2030
10.5.1. Implantable Cardioverter Defibrillators
10.5.2. Cardiac Pacemakers
10.5.3. Cochlear Implants
10.5.4. Spinal Cord Stimulators
10.5.5. Deep Brain Stimulators
10.5.6. Transcutaneous Electrical Nerve Stimulators
10.5.7. Sacral Nerve Stimulators
10.5.8. Vagus Nerve Stimulators
10.5.9. Other
10.6. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
10.6.1. Implantable Electroceutical Devices
10.6.2. Non-invasive Electroceutical Devices
10.7. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
10.7.1. Arrhythmia
10.7.2. Pain Management
10.7.3. Sensorineural Hearing Loss
10.7.4. Parkinson’s Disease
10.7.5. Tremor
10.7.6. Depression
10.7.7. Treatment-resistant Depression
10.7.8. Epilepsy
10.7.9. Urinary and Fecal Incontinence
10.7.10. Others
10.8. Market Size (US$ Mn) and Forecast By End Use, 2023 – 2030
10.8.1. Hospitals
10.8.2. Clinics
10.8.3. Others
11. Competition Analysis
11.1. Market Share Analysis Of Top Vendors
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Key Development Strategies
11.3. Company Profiles
11.3.1. Stimwave LLC
11.3.1.1. Overview
11.3.1.2. Offerings
11.3.1.3. Business Segment & Geographic Overview
11.3.1.4. Key Financials
11.3.1.5. Key Market Developments
11.3.1.6. Key Market Strategy
11.3.2. Nevro Corp.
11.3.3. Sonova
11.3.4. electroCore, Inc.
11.3.5. Biotronik SE & Co. KG
11.3.6. LivaNova PLC
11.3.7. Cochlear Ltd.
11.3.8. Boston Scientific Corporation
11.3.9. Abbott
11.3.10. Medtronic

"